AI Science Tracker
EN

Neural pathology quantification links enlarged brain spaces to vascular amyloid

Massachusetts General Hospital; Harvard Medical School; University College London; Massachusetts Institute of Technology; Leiden University Medical Center · 20 Dec 2021 · medicine

Discovery

Neural pathology quantification links enlarged brain spaces to vascular amyloid

Source check: Source checked. Not independent scientific confirmation.

Finding: Convolutional models quantified vascular amyloid and related pathology in donated brain tissue. In 19 cerebral-amyloid-angiopathy cases, enlarged perivascular spaces were associated with amyloid burden in overlying vessels after accounting for other pathology. Paired MRI and histology supported anatomical interpretation. Cross-sectional autopsy findings do not establish impaired clearance as the cause or the sequence of changes.

Technology: Aiforia convolutional neural networks; three-dimensional U-Net; SmartInterpol

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Validated CNNs quantify vascular amyloid/fibrin pathology, while learned high-resolution MRI segmentation supports regional anatomical analysis.
Test and result
Cross-sectional autopsy tissue quantification, regional MRI/histology comparisons and mixed-effects association analysis in 19 amyloid-angiopathy cases.
Limitation / still unknown
Causal direction, clearance dynamics and population generalizability remain unestablished; the selected donation cohort was small and automated in-vivo MRI segmentation was not reliable.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC9047512/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Primary relevant model Methods, Results and limitations; exact primary identity and current primary PubMed correction/retraction relationships checked..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.